Trial intelligence / Profile preview

HSK3486 Dose-Escalation in Healthy Females

NCT04037657Phase 1Completed

Sponsor
Sichuan Haisco Pharmaceutical Co., Ltd.
Start
Apr 2015
Primary completion
Jun 2015
Modality
Allosteric Modulators
01

Overview

Phase 1, randomised trial of ciprofol in Anesthesia and sedation (2 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Safety by measurement of Adverse Events at Day 1, Bispectral index at Day 1 and 1 more. Started Apr 2015; status: completed.

02

Drugs

ciprofol
03

Conditions

Anesthesiasedation

Beyond the preview

Go deeper on NCT04037657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04037657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call